Xuriden (uridine triacetate) has
been approved by the US Food and
Drug Administration, as the first
ever FDA-approved treatment for
hereditary orotic aciduria.
Hereditary orotic aciduria is a
rare metabolic disorder, due to a
defective enzyme, resulting in the
body being unable to synthesize
uridine, a necessary component of
ribonucleic acid (RNA).
The disease has affected around 20
patients worldwide, the FDA said.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Sep 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.